Proficio Capital Partners LLC Invests $1.38 Million in Bath & Body Works, Inc. (NYSE:BBWI)

Proficio Capital Partners LLC bought a new position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund bought 35,552 shares of the company's stock, valued at approximately $1,378,000.

Other hedge funds have also added to or reduced their stakes in the company. Fifth Third Wealth Advisors LLC lifted its stake in shares of Bath & Body Works by 4.9% in the 4th quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company's stock worth $271,000 after purchasing an additional 324 shares during the period. SRS Capital Advisors Inc. raised its position in Bath & Body Works by 99.7% in the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock worth $26,000 after acquiring an additional 329 shares during the period. TD Private Client Wealth LLC boosted its stake in shares of Bath & Body Works by 24.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company's stock worth $54,000 after acquiring an additional 331 shares during the last quarter. UMB Bank n.a. grew its position in shares of Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after acquiring an additional 335 shares during the period. Finally, Cornerstone Investment Partners LLC grew its position in shares of Bath & Body Works by 3.8% during the 4th quarter. Cornerstone Investment Partners LLC now owns 12,248 shares of the company's stock valued at $475,000 after acquiring an additional 452 shares during the period. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Analyst Upgrades and Downgrades

BBWI has been the topic of several analyst reports. Citigroup upgraded Bath & Body Works from a "neutral" rating to a "buy" rating and lifted their target price for the company from $40.00 to $48.00 in a research report on Friday, February 28th. Telsey Advisory Group reissued an "outperform" rating and issued a $43.00 target price on shares of Bath & Body Works in a report on Thursday, February 27th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Bath & Body Works from $51.00 to $52.00 and gave the company a "buy" rating in a report on Tuesday, November 26th. Barclays reduced their price objective on shares of Bath & Body Works from $43.00 to $38.00 and set an "equal weight" rating for the company in a research note on Monday, March 3rd. Finally, Robert W. Baird lifted their target price on shares of Bath & Body Works from $45.00 to $47.00 and gave the company an "outperform" rating in a research note on Friday, February 28th. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $45.06.

Bath & Body Works Trading Up 7.2 %

Shares of BBWI stock traded up $2.19 on Monday, reaching $32.47. The company's stock had a trading volume of 6,723,627 shares, compared to its average volume of 4,260,691. The stock's fifty day simple moving average is $35.70 and its 200-day simple moving average is $33.99. Bath & Body Works, Inc. has a 1 year low of $26.21 and a 1 year high of $52.99. The company has a market capitalization of $6.96 billion, a price-to-earnings ratio of 7.92, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported $2.09 EPS for the quarter, topping analysts' consensus estimates of $2.04 by $0.05. The business had revenue of $2.79 billion during the quarter, compared to analysts' expectations of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. Equities research analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works declared that its Board of Directors has approved a share buyback program on Thursday, February 27th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to reacquire up to 6.4% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's board believes its shares are undervalued.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a yield of 2.46%. Bath & Body Works's dividend payout ratio (DPR) is presently 21.98%.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.